Baker Bros. Advisors’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $611M | Sell |
|
|||||
|
2020
Q4 | $1.37B | Hold |
|
|||||
|
2020
Q3 | $1B | Hold |
|
|||||
|
2020
Q2 | $983M | Hold |
|
|||||
|
2020
Q1 | $787M | Buy |
|
|||||
|
2019
Q4 | $893M | Hold |
|
|||||
|
2019
Q3 | $809M | Hold |
|
|||||
|
2019
Q2 | $1.08B | Sell |
|
|||||
|
2019
Q1 | $1.16B | Buy |
|
|||||
|
2018
Q4 | $833M | Hold |
|
|||||
|
2018
Q3 | $1.19B | Hold |
|
|||||
|
2018
Q2 | $1.06B | Hold |
|
|||||
|
2018
Q1 | $954M | Buy |
|
|||||
|
2017
Q4 | $1.02B | Hold |
|
|||||
|
2017
Q3 | $1.2B | Hold |
|
|||||
|
2017
Q2 | $1.04B | Buy |
|
|||||
|
2017
Q1 | $793M | Buy |
|
|||||
|
2016
Q4 | $801M | Hold |
|
|||||
|
2016
Q3 | $802M | Hold |
|
|||||
|
2016
Q2 | $764M | Buy |
|
|||||
|
2016
Q1 | $911M | Hold |
|
|||||
|
2015
Q4 | $1.25B | Hold |
|
|||||
|
2015
Q3 | $1.02B | Hold |
|
|||||
|
2015
Q2 | $1.18B | Buy |
|